DNM1L and hematologic disorder: Misexpression of DNM1L and Mfn1/2 may underlie several human hematological malignancies including acute myeloid leukemia (AML), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes1,2.